Portfolio Diversification Through Seeding Israeli Innovation
- Friday, May 17, 2013 at 8:00 am, Chicago, IL
Brian Rosenzweig, Managing Partner/VP of Development of JANVEST Technologies, LLC discussed the increase of capital investment in Israel-based start-ups and Israel's technology investment gap. He also discussed JANVEST's investment strategies and highlighted several portfolio companies.
Pictured at left (left to right) are program host Ted Banks of Scharf Banks Marmor LLC and member of the Board of Directors of the America-Israel Chamber of Commerce Chicago; and Brian Rosenzweig.
Over 125 industry and professional leaders participated in the North America-Israel Biotech Conference (NAIBC).
Left: Host Len Ferber, Katten Muchin Rosenman LLP, welcomes participants. Len is a Partner at Katten and Chair of the firm's Technology Practice. He is a member of the Board of Directors of the America-Israel Chamber of Commerce Chicago.
NAIBC featured the members of the Israeli delegation to the Bio International Convention (BIO), remarks from Israel's Deputy Chief Scientist Abraham Gross, and an international panel discussion on R&D partnerships with Israel. The panel was moderated by Ron Law, Vice President New Frontier Science, Takeda Pharmaceuticals International. Panelists were Nissim Darvish, Senior Managing Director, OrbiMed Advisors; John Frels, Vice President Diagnostics Research, Abbott Diagnostics; Yuji Lizawa, Senior Investment Director, Takeda Ventures Inc.; Norbert Riedel, Chief Science and Innovation Officer (ret), Baxter International; Gary Gabrielsen, Vice President, Business Development & Alliance Management, Astellas U.S. LLC; and Stan Bukofzer, Corporate Vice President and Chief Mdical Oficer, Hospira. NAIBC was presented by the Government of Israel Economic Mission to the Midwest, the Office of the Chief Scientist, the Israeli Industry Center for R&D, and the America-Israel Chamber of Commerce Chicago. Katten Muchin Rosenman LLP was the host and primary sponsor with the Illinois Science + Technology Park as a co-sponsor.
Above: The Israel pavilion on the floor of BIO. Israel-based companies participating in NAIBC and BIO included BioCEP Ltd., BioLineRx, Brainsway, Compugen Ltd., ELMindA Ltd., Estar Technolo- gies Ltd. (Estar Medical), EyeYon Medical, Foamix, HIL Applied Med-ical, Ltd., Immune Pharmaceuticals Ltd., Immune System Key Ltd.-ISK, IonMed Ltd., ITTN, Oramed, PixCell Medical Technologies Ltd., Pluristem Therapeutics, PolyPid Ltd., Protalix, Proteologics, RDD Pharma Ltd., Shulov Innovative Science Ltd.
Medical Design: From Home Healthcare Devices to the Operating Room of the Future
- Wednesday, April 10, 2013, Skokie, IL
Dr. Noemi Bitterman, head of The Technion's Industrial Design Program at the Faculty of Architecture & Town Planning, discussed medical design from the operating room, to uniforms, and devices. Her remarks focused on making the latest technology both ergonomic and practical for use.
Pictured at left (left to right) are program host Michael Rosen of the Illinois Science + Technology Park and Senior Vice-President of the America-Israel Chamber of Commerce Chicago; Dr. Noemi Bitterman; and James Ginsburg, Senior Vice-President of the Chicago Chapter of American Technion Society.
OurCrowd: A New Way to invest in the Start-up Nation - Thursday, April 4, 2013, Highland Park, IL - Friday, March 8, 2013, Chicago, IL
Seventy investors and business leaders joined us for discussions of crowdfunding with Jonathan Medved (left), Chief Executive Officer of OurCrowd Ltd.
The April 4 program was hosted by sculptor Jim Budish and the March 8 program was hosted at 1871, with lunch sponsored by Michael Traison and Miller Canfield Paddock and Stone.
The programs were presented with the Government of Israel Economic Mission to the Midwest, and was hosted at 1871. Lunch was sponsored by Michael Traison and Miller Canfield Paddock and Stone, P.L.C.
Below, Yariv Becher (below, top left), Consul for Economic Affairs, Government of Israel Economic Mission to the Midwest welcomes program attendees.
information are provided "as is" and without warranties of any kind either
express or implied. To the fullest extent permissible pursuant to applicable
law, the America - Israel Chamber of Commerce Chicago (AICC) explicitly
disclaims any responsibility for the accuracy, reliability, content or
availability of the information. AICC does not endorse, recommend or otherwise
evaluate any business, industry, company, investment or project opportunity. It
is, therefore, the responsibility of each AICC member, program participant
and/or user to independently examine and verify the validity of the